Insulin Maker Learns Brutal Lesson: Sometimes Innovation Doesn’t Pay

For almost a century, Novo Nordisk rolled out new versions of its core product at higher prices. Then suddenly, customers including governments and insurers decided the older, less expensive versions were good enough.

[dpp]
EOF

Vote on this story -->>>


Comments are closed.

this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami